|
IT1278077B1
(it)
|
1995-05-25 |
1997-11-17 |
Angeletti P Ist Richerche Bio |
Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
|
|
FR2761695B1
(fr)
*
|
1997-04-04 |
1999-09-24 |
Bio Merieux |
Arn polymerase fonctionnant preferentiellement sur matrice d'arn, sa preparation et son utilisation
|
|
JP2001526028A
(ja)
|
1997-12-11 |
2001-12-18 |
スミスクライン・ビーチャム・コーポレイション |
Ｃ型肝炎ウイルスｎｓ５ｂ末端切断タンパク質およびその抗ウイルス化合物同定方法
|
|
EA200700564A1
(ru)
|
1998-02-25 |
2007-08-31 |
Эмори Юниверсити |
2`-фторнуклеозиды
|
|
JP2002510509A
(ja)
*
|
1998-04-02 |
2002-04-09 |
バイロファーマ・インコーポレイテッド |
Ｃ型肝炎ウイルスｎｓ５ｂ組成物およびその使用方法
|
|
WO1999067396A1
(en)
*
|
1998-06-24 |
1999-12-29 |
International Reagents Corporation |
Hcv-derived rna polymerase gene
|
|
AU2181800A
(en)
*
|
1998-12-10 |
2000-06-26 |
Eli Lilly And Company |
Primer-independent rna synthesis catalyzed by hcv polymerase
|
|
EP1634888A3
(en)
|
1999-11-12 |
2007-11-21 |
Pharmasset, Inc. |
Synthesis of 2'-deoxy-L-nucleosides
|
|
CA2389691A1
(en)
*
|
2000-04-07 |
2001-10-18 |
Shionogi & Co., Ltd. |
A pre-incubation method for an assay of an inhibitor to an hcv rna-dependent rna polymerase
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
YU92202A
(sh)
|
2000-05-26 |
2006-01-16 |
Idenix (Cayman) Limited |
Metode i smeše za lečenje flavi virusa i pesti virusa
|
|
GB0029539D0
(en)
*
|
2000-12-04 |
2001-01-17 |
Isis Innovation |
Method for identifying modulatorss of transcription
|
|
IL156457A0
(en)
*
|
2001-01-31 |
2004-01-04 |
Bristol Myers Squibb Pharma Co |
An in-vitro method for genomic replication
|
|
US7452705B2
(en)
*
|
2001-05-22 |
2008-11-18 |
The University Of Chicago |
N4 virion single-stranded DNA dependent RNA polymerase
|
|
WO2003025156A2
(en)
*
|
2001-09-18 |
2003-03-27 |
Affinium Pharmaceuticals, Inc. |
Methods and apparatuses for purification
|
|
US20030104445A1
(en)
*
|
2001-09-25 |
2003-06-05 |
Hayes Robert J. |
RNA dependent RNA polymerase mediated protein evolution
|
|
JP2005504087A
(ja)
|
2001-09-28 |
2005-02-10 |
イデニクス（ケイマン）リミテツド |
４’が修飾されたヌクレオシドを使用するｃ型肝炎ウイルス治療のための方法および組成物
|
|
KR100447578B1
(ko)
*
|
2001-11-01 |
2004-09-07 |
주식회사 이매진 |
Ｈｃｖ 자가 복제 효소 활성의 세포내 측정용 키트 및측정 방법
|
|
US20030114409A1
(en)
*
|
2001-11-16 |
2003-06-19 |
Mello Craig C. |
Facilitation of RNA interference
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
PT1523489E
(pt)
|
2002-06-28 |
2014-06-24 |
Centre Nat Rech Scient |
Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae
|
|
PT1576138T
(pt)
|
2002-11-15 |
2017-05-03 |
Idenix Pharmaceuticals Llc |
2'-metil-nucleósidos em combinação com interferão e mutação de flaviviridae
|
|
SI2604620T2
(sl)
|
2003-05-30 |
2024-10-30 |
Gilead Pharmasset Llc |
Modificirani fluorirani nukleozidni analogi
|
|
US20050075309A1
(en)
|
2003-07-25 |
2005-04-07 |
Richard Storer |
Purine nucleoside analogues for treating Flaviviridae including hepatitis C
|
|
US7329732B2
(en)
*
|
2004-01-09 |
2008-02-12 |
Merck & Co., Inc. |
HCV RNA-dependent RNA polymerase
|
|
WO2006121468A1
(en)
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
|
CN101142226A
(zh)
|
2005-02-28 |
2008-03-12 |
健亚生物科技公司 |
用于治疗病毒感染的三环核苷化合物
|
|
TW200720285A
(en)
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
EP2307434B1
(en)
|
2008-07-02 |
2014-02-12 |
IDENIX Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
EP2166016A1
(en)
|
2008-09-18 |
2010-03-24 |
Centocor Ortho Biotech Products L.P. |
Phosphoramidate Derivatives of Nucleosides
|
|
US8716263B2
(en)
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
|
PA8855601A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Forformidatos de nucleósidos
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
WO2011023801A1
(en)
|
2009-08-31 |
2011-03-03 |
F. Hoffmann-La Roche Ag |
Hcv ns3/4a replicon shuttle vectors
|
|
AU2010317996A1
(en)
|
2009-11-14 |
2012-05-10 |
F. Hoffmann-La Roche Ag |
Biomarkers for predicting rapid response to HCV treatment
|
|
MX2012005703A
(es)
|
2009-12-02 |
2012-06-12 |
Hoffmann La Roche |
Biomarcadores para pronosticar una respuesta prolongada al tratamiento contra el vhc.
|
|
WO2011123668A2
(en)
|
2010-03-31 |
2011-10-06 |
Pharmasset, Inc. |
Stereoselective synthesis of phosphorus containing actives
|
|
US20110245328A1
(en)
|
2010-03-31 |
2011-10-06 |
Hyunsoon Kang |
HCV NS5A Replicon Shuttle Vectors
|
|
JP5872539B2
(ja)
|
2010-03-31 |
2016-03-01 |
ギリアド ファーマセット エルエルシー |
プリンヌクレオシドホスホルアミダート
|
|
WO2011123586A1
(en)
|
2010-04-01 |
2011-10-06 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
AR082453A1
(es)
|
2010-04-21 |
2012-12-12 |
Novartis Ag |
Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
|
|
AU2011281546B2
(en)
|
2010-07-22 |
2014-07-10 |
Novartis Ag |
2,3,5-trisubstituted thiophene compounds and uses thereof
|
|
EP2646453A1
(en)
|
2010-11-30 |
2013-10-09 |
Gilead Pharmasset LLC |
Compounds
|
|
US9351989B2
(en)
|
2010-12-29 |
2016-05-31 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
|
EP2691409B1
(en)
|
2011-03-31 |
2018-02-21 |
Idenix Pharmaceuticals LLC. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
AR088441A1
(es)
|
2011-09-12 |
2014-06-11 |
Idenix Pharmaceuticals Inc |
Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales
|
|
AU2012308900A1
(en)
|
2011-09-12 |
2013-05-09 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
EP2768838A1
(en)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
PL3038601T3
(pl)
|
2013-08-27 |
2020-08-24 |
Gilead Pharmasset Llc |
Formulacja złożona dwóch związków przeciwwirusowych
|